Raymond James Financial
NXL icon

Raymond James Financial’s Nexalin Technology NXL Stock Holding History

Raymond James Financial’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.21K Buy
+12,100
New +$6.3K ﹤0.01% 5274

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial's NXL Position: Q1 2026 in Review

Raymond James Financial opened a new position in Nexalin Technology (NXL) in Q1 2026: 12,100 shares worth $4.21K. The stake represents ﹤0.01% of the portfolio and ranks #5274 among its holdings.

23 funds tracked by Wall St. Rank hold NXL as of Q1 2026.

  • Raymond James Financial held 12,100 shares of Nexalin Technology worth $4.21K as of Q1 2026.
  • Nexalin Technology was a new Raymond James Financial position in Q1 2026.
  • Nexalin Technology made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #5274 holding.
  • 23 funds tracked by Wall St. Rank held Nexalin Technology as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.